Patents by Inventor Laura Leyva Fernández

Laura Leyva Fernández has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR PREDICTING OR PROGNOSTICATING THE RESPONSE TO THE TREATMENT OF MULTIPLE SCLEROSIS WITH INTERFERON BETA
    Publication number: 20220043006
    Abstract: A method for predicting or prognosticating the response of individuals with multiple sclerosis to treatment with IFN?, kit or device, and uses.
    Type: Application
    Filed: October 2, 2019
    Publication date: February 10, 2022
    Inventors: Begoña OLIVER MARTOS, Laura LEYVA FERNÁNDEZ, Isaac HURTADO GUERRERO, Óscar FERNÁNDEZ FERNÁNDEZ, Jose PAVIA MOLINA
  • Methods for treating or ameliorating multiple sclerosis
    Patent number: 10393758
    Abstract: The invention relates to a recombinant protein and uses thereof in the diagnosis and treatment of multiple sclerosis. The invention also relates to the recombinant protein IFNAR2.3, antibodies, compositions comprising same, and uses thereof. Among the uses thereof, the invention especially relates to a method for the diagnosis of multiple sclerosis, and to the diagnosis kit. The invention further relates to the use of the protein IFNAR2.3 in the preparation of a medicament for the treatment of multiple sclerosis.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: August 27, 2019
    Assignee: UNIVERSIDAD DE MALAGA
    Inventors: Óscar Fernández Fernández, Begoña Oliver Martos, Teresa Órpez Zafra, José Pavía Molina, Cristobalina Mayorga Mayorga, Laura Leyva Fernández, María Jesús Pinto Medel, Margarita Suardíaz García
  • RECOMBINANT PROTEIN AND USES THEREOF IN THE DIAGNOSIS OF MULTIPLE SCLEROSIS
    Publication number: 20160011212
    Abstract: The invention relates to a recombinant protein and uses thereof in the diagnosis and treatment of multiple sclerosis. The invention also relates to the recombinant protein IFNAR2.3, antibodies, compositions comprising same, and uses thereof. Among the uses thereof, the invention especially relates to a method for the diagnosis of multiple sclerosis, and to the diagnosis kit. The invention further relates to the use of the protein IFNAR2.3 in the preparation of a medicament for the treatment of multiple sclerosis.
    Type: Application
    Filed: November 22, 2013
    Publication date: January 14, 2016
    Inventors: Óscar Fernández Fernández, Begoña Oliver Martos, Teresa Órpez Zafra, José Pavía Molina, Cristobalina Mayorga Mayorga, Laura Leyva Fernández, María Jesús Pinto Medel, Margarita Suardíaz García